InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Galson Steven K, Director. Officer active across 1 company, notably Biocryst Pharmaceuticals INC. In total, 5 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €112k. Activity tracked since 7 June 2022. The latest transaction was filed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations
Steven K. Galson is a Director at BIOCRYST PHARMACEUTICALS INC. He contributes to corporate governance and the strategic direction of the company. As a board member, he participates in important decision-making and oversight of BIOCRYST's operations. His experience in the biopharmaceutical sector is an asset for the company.